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ABSTRACT Airway hyperresponsiveness is a major characteristic of asthma and is believed to result from the excessive
contraction of airway smooth muscle cells (SMCs). However, the identiﬁcation of the mechanisms responsible for airway
hyperresponsiveness is hindered by our limited understanding of how calcium (Ca21), myosin light chain kinase (MLCK), and
myosin light chain phosphatase (MLCP) interact to regulate airway SMC contraction. In this work, we present a modiﬁed
Hai-Murphy cross-bridge model of SMC contraction that incorporates Ca21 regulation of MLCK and MLCP. A comparative ﬁt of
the model simulations to experimental data predicts 1), that airway and arteriole SMC contraction is initiated by fast activation by
Ca21 of MLCK; 2), that airway SMC, but not arteriole SMC, is inhibited by a slower activation by Ca21 of MLCP; and 3), that the
presence of a contractile agonist inhibits MLCP to enhance the Ca21 sensitivity of airway and arteriole SMCs. The implication of
these ﬁndings is that murine airway SMCs exploit a Ca21-dependent mechanism to favor a default state of relaxation. The rate
of SMC relaxation is determined principally by the rate of release of the latch-bridge state, which is predicted to be faster in
airway than in arteriole. In addition, the model also predicts that oscillations in calcium concentration, commonly observed
during agonist-induced smooth muscle contraction, cause a signiﬁcantly greater contraction than an elevated steady calcium
concentration.
INTRODUCTION
Airway hyperresponsiveness is a characteristic of asthma and
is generally ascribed to the excessive contraction of airway
smooth muscle cells (SMCs). Although individual cells may
generate more force, this change may also occur because of
an increase in SMCmass, an increased sensitivity to agonists,
or a reduction in elastic recoil forces (1). To determine the
role of the individual SMC in airway hyperresponsiveness,
we focused on the cellular mechanisms that regulate and
produce airway SMC contraction.
Airway SMC contraction is initiated by a rise in intracel-
lular Ca21 concentration ([Ca21]i), which, in turn, sequen-
tially activates Ca21-calmodulin and myosin light chain
kinase (MLCK). MLCK phosphorylates the regulatory light
chain of myosin (rMLC), allowing myosin to enter the cross-
bridge cycle with actin to generate a sliding force to contract
the SMC. Relaxation of the SMCs essentially requires a de-
crease in [Ca21]i, but the extending force is passive and is
provided by the elastic recoil of the lung parenchyma coupled
with breathing.
Although this basic idea of airway SMC contraction is well
accepted, there are a number of important processes that have
major implications for the regulation of SMC contractility.
First, in normal airway and arteriole SMCs, the increase in
[Ca21]i does not occur as a uniform steady-state increase but
occurs as a series of oscillatory Ca21 waves that propagate
along the SMCs (2–5). Second, the contractile sensitivity of
the SMCs to [Ca21]i can be substantially regulated by the
stimulating agonist (6). Third, and perhaps the most unex-
pected specialization of mouse airway SMCs, sustained el-
evated [Ca21]i induces airway relaxation (5). Although the
Ca21 oscillations initiate contraction, it is the relative Ca21-
dependent activities of MLCK and myosin light chain
phosphatase (MLCP) that determine the sustained contractile
state.
In normal mouse lung slices, the addition of agonists ini-
tiates contraction of the airways (MCh and 5-HT) and arte-
rioles (5-HT only) by initiating Ca21 oscillations in the
SMCs (3,4). However, to determine the contribution of Ca21
sensitization to the contractile state, it is necessary to main-
tain the [Ca21]i at a steady state. This was achieved by si-
multaneously treating the lung slices with caffeine and
ryanodine. Caffeine activates the ryanodine receptor, allow-
ing ryanodine access to lock the ryanodine receptor in an
open state. This treatment results in emptying the internal
Ca21 stores of the airway and arteriole SMCs, which leads to
a sustained inﬂux of Ca21, presumably via store-operated
channels. By varying the external calcium concentration, the
internal [Ca21]i of the SMCs can be experimentally clamped.
As expected with this caffeine-ryanodine treated lung
slice, [Ca21]i-induced contraction increases in both the air-
way and arteriole SMCs. The ﬁrst key result was that in the
presence of this sustained increase in [Ca21]i, the airway
SMCs subsequently relaxed (Fig. 1). However, under iden-
tical conditions, the adjacent arteriole SMCs remained con-
tracted (Fig. 1). To explain this Ca21-induced airway
relaxation, we hypothesized that the increase in [Ca21]i
activates airway MLCP (either directly or indirectly) on a
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relatively slow timescale, compared to the Ca21 activation of
MLCK, to reduce rMLC phosphorylation and hence force
production. By contrast, we proposed the arteriole MLCP to
be insensitive to Ca21.
The second key result was that upon the subsequent ex-
posure to a contractile agonist (5-HT), the relaxed airway
recontracted whereas the arteriole displayed a further con-
traction even though the [Ca21]i in either SMC type remained
high and unchanged (Fig. 1). Therefore, we proposed that
the agonist also stimulates a Ca21-independent inhibition of
MLCP (in both the airway and arteriole) to enhance force
production.
Here we develop a mathematical model to analyze how the
Ca21- and agonist-dependent activity of the MLKC and
MLCP are responsible for the ﬁnal rMLC phosphorylation
and SMC contraction. The model is based on the experi-
mental responses of airway and arteriole SMCs in lung slices
under steady-state Ca21 conditions and explicitly considers
the length changes of SMCs during contraction. Because the
agonist simultaneously stimulates both Ca21 oscillations and
increases in Ca21 sensitivity, it is difﬁcult to determine ex-
perimentally the relative importance of each mechanism in
the regulation of SMC contraction and how these may be
altered to result in hyperresponsiveness. Consequently, we
used the model to evaluate the inﬂuence of Ca21 oscillations
on airway and arteriole SMC. Previous mathematical models
have concentrated on airway SMC. They relied on force
generation data of isolated SMCs under isometric conditions
or measurement of the resistance of the whole airway and did
not include the regulation of MLCP (7–13).
THE MODEL
To understand the complex dynamics of SMC contraction,
we expanded the Hai-Murphy cross-bridge model (7) to in-
clude Ca21 activation of MLCK, Ca21 activation of MLCP,
and agonist inactivation of MLCP. Our model is based on
the modiﬁcation of the Hai-Murphy cross-bridge model by
Mijailovich et al. (7–11). A schematic diagram of the cross-
bridge model is shown in Fig. 2. The key parameters of this
FIGURE 1 Response of an airway and arteriole in a lung slice to agonist
and high [Ca21]i. The experimental data show the simultaneous changes
in airway and arteriole lumen size in response to 5-HT or changes in
extracellular Ca21 and were obtained using the methods detailed in Bai
and Sanderson (5). Normal airways and arterioles were contracted with
1 mM 5-HT. The same lung slice was subsequently treated with caffeine
(20 mM) and ryanodine (50 mM) for 5 min to allow the [Ca21]i to be
experimentally altered. The caffeine and ryanodine were removed by
washing, and the lung slice was equilibrated with zero external Ca21. The
[Ca21]i of individual SMCs was monitored by loading the cells with the
Ca21 reporter dye Oregon green and observing the emitted ﬂuorescence with
confocal microscopy as described by Bai and Sanderson (5). (Top) A phase-
contrast image of the airway and arteriole in a lung slice surrounded by
alveolar parenchyma. Changes in the area of airway or arteriole lumen are
measured to indicate SMC contraction. Image width ¼ 440 mm. (Bottom
left) In response to agonist (200 nM 5-HT), both the airway (blue) and
arteriole (red) reduced their lumen area (normalized to initial area). In
caffeine/ryanodine-treated lung slices (bottom right), the airway and arteri-
ole are fully relaxed in 0 Ca21. The addition of external Ca21 in Hanks’
balanced salt solution (1.3 mM Ca21) raises internal Ca21 and induces
contraction of both the airway and arteriole. However, the airway relaxes,
whereas the arteriole continues to contract to reach a steady state. Upon the
addition of agonist, the airway fully recontracts (similar to the normal slice),
whereas the arteriole displays a further contraction. Removal of the agonist
allows the relaxation of both airway and arteriole even though the [Ca21]i
remains high. Removal of extracellular Ca21 allows the arteriole to fully
relax.
FIGURE 2 Schematic diagram of the model. M denotes myosin, AM
denotes myosin attached to actin, and a subscript p denotes the phosphor-
ylated state of the rMLC. Active force generation results from cycling
betweenMp and AMp. However, cycling cross-bridges can be dephosphory-
lated into the latch state, AM, where they can neither exert active force nor
relax quickly. We assume that the rate of phosphorylation of myosin is
unaffected by its attachment to actin. k1 is the rate of M and AM phosphor-
ylation by MLCK, and k2 is the rate of M and AM dephosphorylation by
MLCP. The rate constants fp(x), gp(x), and g(x) are position dependent, as
described in The Model.
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model relevant to our experimental data are k1, the rate of
rMLC phosphorylation by MLCK, and k2, the rate of rMLC
dephosphorylation byMLCP. Both are assumed independent
of whether or not the myosin is attached to actin (8).
rMLC phosphorylation
k1: the rate of rMLC phosphorylation by MLCK
The coupling of Ca21 to the sliding of actin and myosin ﬁl-
aments occurs via the activation of MLCK by calmodulin,
which itself is activated by the binding of Ca21. In SMCs,
contraction is slow enough that the interaction of Ca21 with
calmodulin and MLCK can be assumed to be at quasi steady
state. Let c denote the [Ca21]i in the cytoplasm. Assuming
that calmodulin is activated by four Ca21 ions, we model
the combined activity of calmodulin and MLCK on rMLC
phosphorylation, k1, as
k1 ¼ k1ac
4
k
4
1b1 c
4:
k2: the rate of rMLC dephosphorylation by MLCP
Our experimental results suggest that the rate of rMLC de-
phosphorylation, k2, depends on both [Ca
21]i (c) and agonist
concentration (a) and is time dependent. Therefore we in-
troduced an additional differential equation for P, the fraction
of activated MLCP:
tp
dP
dt
¼ konðcÞð1 PÞ  koffðaÞP; (1)
k2 ¼ k˜2P2; (2)
where
konðcÞ ¼ kon11 c
2
k
2
on21 c
2; (3)
koffðaÞ ¼ koff11 koff2a
11 a
; (4)
and tp is a time constant.
The exponent 2 in Eq. 2 was chosen to give good agree-
ment with experimental data; an exponent of 1 did not ﬁt the
data as well (sum of squared residuals 1.5 and 4.3, respec-
tively, F-ratio test p , 0.01). Since the mechanisms of ago-
nist-induced Ca21 sensitization (or inhibition of MLCP) are
not fully understood and can vary with the agonist, tissue, and
SMC type (14), we adopted the strategy of omitting the de-
tailed reactions and assuming simple direct relationships with
plausible functional forms. Thus, for example, the activation
of MLCP is assumed to depend directly on the calcium
concentration, c, not on the concentration of calcium/cal-
modulin or through any other intermediate reactions. Con-
sequently, we used a Hill function to model a generic
increasing dependence on c. Similarly, inactivation of MLCP
by agonist is assumed to depend directly on the agonist
concentration, even though this is a drastic simpliﬁcation.We
are aware that there are a number of possible intermediate
reactions between the agonist and its effect on MLCP, but
for this model it sufﬁces to assume that the rate of inactivation
of MLCP is an increasing function of the agonist concen-
tration, a.
The cross-bridge model
The attachment of myosin to actin depends on its phos-
phorylated state and its position with respect to the binding
site on the actin ﬁlament. We denote by the local coordinate x
the distance between the binding site on the actin ﬁlament
and the equilibrium position of the cross-bridge. The distri-
bution of cross-bridges at x is determined by
@M
@t
 vðtÞ@M
@x
¼ k1M1 k2Mp1 gðxÞAM; (5)
@Mp
@t
 vðtÞ@Mp
@x
¼ k1M  ðk21 fpðxÞÞMp1 gpðxÞAMp; (6)
@AMp
@t
 vðtÞ@AMp
@x
¼ k1AM1 fpðxÞMp  ðgpðxÞ1 k2ÞAMp;
(7)
subject to the constraint M 1 Mp 1 AMp 1 AM ¼ 1, where
v(t) is the velocity of the actin ﬁlament relative to the myosin
ﬁlament, deﬁned to be positive during shortening. The rate
constants fp(x), gp(x), and g(x) are based onMijailovich et al. (8):
fpðxÞ ¼
0; x, 0;
fp1x
h
; 0# x# h;
0; x. h;
8><
>:
gpðxÞ ¼
3ðfp11 gp1Þ; x, 0;
gp1x
h
; 0# x# h;
4gp1x
h
; x. h;
8><
>>:
gðxÞ ¼
20g1; x, 0;
g1x
h
; 0# x# h
g1; x. h
8><
>:
where h, the largest displacement at which a cross-bridge can
become attached to the thin ﬁlament, is 15.6 nm (8,9,15). For
simplicity we deﬁne h ¼ 1 unit length ¼ 15.6 nm.
We assume that an attached cross-bridge, independent of
its phosphorylation state, generates a force that depends on its
displacement. The total force generated by SMCs is pro-
portional to the ﬁrst moment of the AM and AMp distribution
F ¼ k
Z N
N
xðAMp1AMÞdx: (8)
Force balance
We assume that the SMCs are organized in a ring around an
airway of radius R(t) and exert a tangential force. We also
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assume that this ring is embedded in a linearly elastic, iso-
tropic homogeneous sheet, with the airway positioned at the
center. For simplicity we assume radial symmetry and deﬁne
the displacement ur ¼ R  R0, where R0 is the radius at rest
(i.e., when the SMCs are exerting no force). At all times we
neglect inertia and assume that the force exerted by the SMCs
is balanced by the force exerted by the elastic sheet; the
balance of these forces determines the airway radius. Thus,
the transient behavior exhibited by the contraction (as seen in
Fig. 3) is due entirely to the cross-bridge kinetics.
For small displacements the components of the strain
tensor are (16)
err ¼ @ur
@r
; euu ¼ ur
r
; eur ¼ eru ¼ 0: (9)
Assuming Hooke’s law for the elastic medium, the stress
components are
srr ¼ lðerr1 euuÞ1 2merr; (10)
suu ¼ lðerr1 euuÞ1 2meuu; (11)
and sur¼ sru¼ 0, where l and m are the two Lame´ constants
that characterize the elastic medium.
If Nc SMCs are arranged serially around an airway of ra-
dius, R, with each exerting a tangential force, F, the total
radial force is NcF/R. Note that, as the radius increases, the
total radial force decreases although the tangential force re-
mains the same. Thus the boundary conditions for the stress
are
srrðr ¼ RÞ ¼ NcF=R; srrðr ¼NÞ ¼ 0: (12)
In mechanical equilibrium, the equation for conservation of
linear momentum is
@srr
@r
1
1
r
ðsrr  suuÞ ¼ 0: (13)
Using Eqs. 9–11 we obtain
ðl1 2mÞ @
@r
1
r
@urr
@r
 
¼ 0; (14)
which, together with the boundary conditions Eq. 12, gives
ur ¼ R R0 ¼ NcF
2m
: (15)
Note that the displacement is now independent of the radius
of the airway. The 1/R dependence in the expression for the
radial strain cancels out with the radial dependence in the
solution of the linear momentum equation. Although this is
true for the simple radially symmetric case we consider here,
it is not true in general for more complicated geometries.
Similarly, this solution relies on the assumption of linear
elasticity.
All results are given as relative area (i.e., fraction of airway
(arteriole) area divided by the area at rest), which is deter-
mined by the balance between the tethering of the medium
surrounding the airway and the force exerted by the SMCs.
The radius at rest, R(0), is determined by the steady-state
cross-bridge distribution at given initial agonist and calcium
concentrations. The relative area is then R.A.(t) ¼ pR(t)2/
pR(0)2. Using Eqs. 8 and 15 and R(0)¼ NcL0/2p with L0 the
length of an SMC for F ¼ 0, we obtain
R:A:ðtÞ ¼ 1 b
RN
N xðAMðx; tÞ1AMpðx; tÞÞdx
 2
1 b RNN xðAMðx; 0Þ1AMpðx; 0ÞÞdx 2
; (16)
where we introduced the dimensionless parameter b ¼
pk/(L0m).
Contraction velocity
As the airway radius changes, the velocity of the cross-bridges
must also be calculated as a function of time, as the contrac-
tion velocity affects the force generated by the SMC. Iso-
metric solutions are qualitatively different from the solutions
shown here (computations not shown).
FIGURE 3 Contraction of airway SMCs in response to step changes in
sustained high [Ca21]i (c) in the absence and presence of agonist (a). (A)
Experimental data (solid) with the model ﬁt (dashed). (B) The corresponding
MLCP (k2) and MLCK activity (k1) induced by changes in c and a. (C)
The corresponding fractions of AM and AMp. The simulation was done by
changing c as follows: c ¼ 0.1 mM for 1 min, c ¼ 0.65 mM for 10 min, c ¼
1.3 mM for 8 min, c ¼ 0.65 mM for the remaining time. To simulate the
experimental change in c, every step increase in c required 1 min to reach the
next level of [Ca21]i. The agonist concentration a is increased from 0 to 6.0
after 22 min.
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We assume that each SMC contains N contractile units,
arranged serially, and that each contractile unit contracts from
both ends and therefore has a shortening velocity of 2hv(t).
Thus the SMC has shortening velocityN2hv(t). Using Eq. 15,
we obtain a relation between velocity and force
dR
dt
¼ Nc
2m
dF
dt
¼ NNch
p
vðtÞ: (17)
With Eq. 8 the velocity reads
vðtÞ ¼ g
Z N
N
x
@AM
@t
1
@AMp
@t
 
dx: (18)
Here we introduce the dimensionless parameter g ¼ pk/
(2mNh) ¼ L0/(2Nh)b. The quantity L0/N corresponds ap-
proximately to the length of a contractile unit. Integration by
parts gives a formula to compute the velocity
vðtÞ ¼ g
RN
N xðfpðxÞMp  gðxÞAM  gpðxÞAMpÞdx
11 g
RN
NðAMp1AMÞdx
: (19)
Note that this computation of the contraction velocity relies
on the assumption that the force exerted by the SMCs is
exactly balanced by the surrounding elastic sheet (Eq. 15).
Thus, the solution procedure is as follows: for a given
calcium concentration we substitute the expression for the
contraction velocity (Eq. 19) into the cross-bridge partial
differential equations, solve numerically (using a midpoint
implicit upwind scheme, as described in the Appendix), and
thus calculate the force generated by the SMCs. The change
in radius is then calculated from the force balance equation
(Eqs. 15 and 16).
RESULTS
Model parameters are listed in Table 1. They were obtained
from the literature or by ﬁtting to the experimental data from
Bai and Sanderson (5) reproduced here in Figs. 3, 4, and 6
(see Appendix). The arteriole model was ﬁtted to the data
shown in the lower right panel of Fig. 1 and the data of Fig. 6.
The experimental data in Figs. 5 and 7 were not used in the
ﬁtting process for the airway but agree very well with the
model results.
How does Ca21 and agonist regulation of MLCP
affect airway contraction?
In response to a step increase in [Ca21]i (Figs. 1 and 3), the
airway initially contracts (because MLCK activity quickly
increases) but subsequently slowly relaxes (because MLCP
activity slowly increases) (Fig. 3, A and B). The model pre-
dicts that during this transient contraction the contractile
force arises mainly from cross-bridges in the latch state. The
initial phosphorylation of myosin allows binding to actin, and
there is a small transient increase in AMp. However, myosin
quickly moves into the latch state (AM) as soon as MLCP
activity begins to increase (Fig. 3 C). Due to the depletion of
the phosphorylated myosin (Mp), a contraction cannot be
maintained and the subsequent relaxation of the airway cor-
relates with the slow dissociation of the latch state from actin.
The second step increase in [Ca21]i (to 1.3 mM) induces a
smaller contractile response (Fig. 3 A). This is consistent with
the fact that the airway SMC has adapted to the elevated
[Ca21]i by increasing MLCP activity. In addition, the con-
tractile effect of the additional activation of MLCK by the
step increase of Ca21 is mitigated by the increased MLCP
activity (Fig. 3 B). The step increase in Ca21 also further
activates the MLCP, and over time the airway relaxes again
but to a level determined by the new equilibrium resulting
from the high activity of both MLCK and MLCP. Further-
more, as shown in Fig. 6, if the airway has not been previ-
ously adapted to high [Ca21]i, the contractile response to the
same increase in [Ca21]i (1.3 mM) is considerably stronger
(compare Fig. 6 to Figs. 1 and 3).
A step decrease in Ca21 serves to relax the airway rap-
idly as the MLCK activity falls in the presence of high
MLCP activity. However, the subsequent addition of agonist
stimulates a substantial airway contraction, often equal to that
observed in normal lung slices. Because the [Ca21]i is still
high and does not change upon agonist addition, this re-
sponse is explained by the agonist inducing a rapid decrease
in the MLCP activity: the agonist is working by turning off
the MLCP (the ‘‘off’’ or relaxation process) rather than by
turning on the MLCK (the ‘‘on’’ or contractile process).
TABLE 1 Parameter values used in the modiﬁed
cross-bridge model
Parameter values determined by ﬁt to the experimental data
Airway model
parameters Values in our model 95% range
k1a 0.5962 s
1 [0.34, 0.88]
k1b 1.35 mM [1.1731, 1.5272]
kon1 0.000125 [0.0001, 0.0002]
kon2 0.8988 mM [0.7551, 1.0377]
koff1 0.4629 [0.3992, 0.5132]
koff2 20.035 [17.7670, 21.7317]
tp 156.9 s [132.8425, 171.6565]
k˜2 242.14 s
1 [164.6281, 337.2143]
g1 0.1211 s
1 [0.1123, 0.1281]
Arteriole model
parameters Values in our model 95% range
kon2 0.000174 mM [0.0001, 0.0006]
koff2 120.84 [107.6515, 136.7734]
tp 564.67 s [533.6403, 595.8495]
k˜2 76.23 s
1 [73.6590, 78.8780]
g1 0.03 s
1 [0.0291, 0.0311]
k1b 0.7 mM From Geguchadze et al. (31)
and Fajmut et al. (32)
Parameter values taken from Mijailovich et al. (8)
fp1 0.88 s
1 gp1 0.22 s
1
Other parameter values
b 2 g 44.87
The values either were determined by ﬁtting to data or were taken from
Mijailovich et al. (8). The 95% conﬁdence intervals are obtained from
MCMC (see Appendix).
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Consequently, the amount of phosphorylated myosin in-
creases. At high agonist concentrations, the model predicts
that both AMp and AM contribute to the contraction (Fig. 3
C). Finally, when the agonist is removed, the MLCK activity
quickly decreases, whereas the MLCP activity remains high.
This results in a fast decrease in the amount of phosphory-
lated myosin and a transient increase in latch-bridge forma-
tion (AM). Because unphosphorylated myosin can only
dissociate from actin, the latch state dissociates to allow the
airway to relax completely.
Under conditions in which the [Ca21]i remains constant,
the airway SMCs respond to increasing concentrations of
agonist by step increases in contraction (Fig. 4 A). It is im-
portant to note that at the beginning of this experiment, the
airway is fully relaxed because the airway has been previ-
ously exposed to high [Ca21]i for an extended period: both
the MLCP and MLCK are active before the addition of ag-
onist. The increased contraction is due to inactivation of
MLCP (Fig. 4 B). Consequently, the model predicts an in-
crease in the amount of phosphorylated myosin as a function
of agonist concentration (Fig. 4 C).
A similar step increase in contraction occurs in response to
step increases in [Ca21]i when the agonist concentration is
held constant (Fig. 5 A). At the beginning of this experiment,
the airway is also fully relaxed, but in this case the [Ca21]i
and agonist concentration were maintained low for an ex-
tended period. Consequently, the MLCK is inactive but the
MLCP has residual activity (Fig. 5 B). From these studies the
model predicts an increase in the amount of phosphorylated
myosin as a function of calcium concentration (Fig. 5 C).
Arteriole MLCP is not regulated by calcium
We applied the same model to both airway and arteriole
SMC. In ﬁtting to the arteriole data of Figs. 6 and 7, six of the
parameters (k1b, kon2, koff2, tp, g1, and k˜2) were changed. All
other parameters were held ﬁxed at the values obtained for
airway SMC.
Airway SMCs and arteriole SMCs respond quite differ-
ently to a step increase in [Ca21]i. In arteriole SMCs, the
initial contraction occurs more slowly, and an adaptive re-
laxation does not occur (Fig. 6, upper panel). Although ki-
nase activity in both airway and arteriole SMCs increases
FIGURE 5 Dependence of airway SMCs contraction on [Ca21]i at a
constant agonist concentration. (A) Experimental data (solid) with model ﬁt
(dashed). (B) The corresponding MLCP (k2) and MLCK activity (k1). (C)
The corresponding fractions of AM and AMp. Initially the agonist concen-
tration a is stepped from 0 to 1.2 and then kept constant. [Ca21]i (c) is
stepped up to 0.115 mM, 0.18 mM, 0.48 mM, and 0.57 mM at 8 min
intervals. Each step increase in c takes 1 min to complete. After 8 min at the
highest [Ca21]i, c is returned to 0.1 mM for the remainder of the simulation.
FIGURE 4 Dependence of airway SMCs contraction on agonist concen-
tration at [Ca21]i ¼ 0.65 mM. (A) Experimental data (solid) with model ﬁt
(dashed). (B) The corresponding MLCP (k2) and MLCK activity (k1). (C)
The corresponding fractions of AM and AMp. The agonist concentration, a, is
initially 0 for 1 min and sequentially increases in steps up to 0.3, 0.6, 1.2, 6.0
at 8 min intervals. After 8 min at the highest agonist concentration, a, is
returned to 0 for the remainder of the simulation.
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when [Ca21]i increases (Fig. 6, lower panel), arteriole
phosphatase activity is independent of [Ca21]i (low kon2,
Table 1). A subsequent increase in agonist concentration
causes a stronger contraction (Fig. 7 A), the result of a de-
crease in phosphatase activity (Fig. 7 B). In arteriole, the
initial Ca21-dependent contraction is maintained by the latch
state AM, but the agonist-dependent contraction is maintained
principally by phosphorylated myosin, AMp (Fig. 7 C). Thus
the model strongly suggests that, unlike airway SMCs, MLCP
in arteriole SMCs is regulated by agonist but not by Ca21.
In both airway and arteriole, relaxation after removal of
Ca21 or agonist is due to dissociation of the latch state from
actin (Figs. 3 C, 4 C, 5 C, and 7 C). However, airway SMCs
relax faster than arteriole SMCs. The model predicts that this
difference is due to a slower dissociation of the latch state
from actin in arteriole SMCs. We found that the dissociation
rate constant g1 in arteriole SMCs is ;4 times smaller than
that in airway SMCs (Table 1).
Response to calcium oscillations
Previous simulations have investigated how the airway and
arteriole contract under conditions where [Ca21]i remains con-
stant. However, in normal SMCs (not treated with ryanodine/
caffeine), exposure to agonist typically generates Ca21 os-
cillations, with a frequency that increases with the agonist
concentration (3,4,17). To analyze the response of airway
SMCs to calcium oscillations, we use a ‘‘square wave’’
(periodic piecewise linear function) to mimic [Ca21]i oscil-
lations. The frequency and form of the [Ca21]i oscillations
was chosen to be approximately equal to that observed during
agonist stimulation.
The model predicts that an oscillatory Ca21 stimulus in-
duces a signiﬁcantly greater contraction than an equivalent
constant Ca21 stimulus with magnitude equal to the average
[Ca21]i during oscillations. This effect is particularly pro-
nounced for the airway.
To show this, we varied the frequency of the Ca21 oscil-
lations while maintaining the same average Ca21 and agonist
concentration (Fig. 8, A and B). Because the average [Ca21]i
remains constant, the high- and low-frequency Ca21 oscillations
FIGURE 7 Response of an airway and arteriole pair to agonist and high
[Ca21]i. This simulation corresponds to Fig. 1 (bottom right). (A) Experi-
mental (solid) and model (dashed) data for the airway (blue) and arteriole
(red). (B) The corresponding arteriole phosphatase (k2) and kinase activity
(k1) induced by changes in c and a. (C) Fractions of arteriole AM and AMp. In
these simulations, [Ca21]i (c) is initially increased to 0.65 mM over a
duration of 1 min. Near the end of the simulation, c is returned to 0.1 mM.
The agonist concentration a is increased from 0 to 6.0 after 9 min.
FIGURE 6 Contraction of an airway and arteriole pair during sustained
high [Ca21]i in the absence of agonist. The upper plot shows experimental
(solid) and model data (dashed) for the airway (blue) and arteriole (red). The
lower plot shows a comparison of the corresponding kinase (left) and
phosphatase (right) activity of the airway (blue) and arteriole (red). In these
simulations, [Ca21]i (c) is initially increased to 1.3 mM over a duration of
1 min. Near the end of the simulation, c is returned to 0.1 mM.
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must necessarily have long and short spike durations, re-
spectively (upper inset of Fig. 8 A). In airway SMCs all Ca21
oscillation frequencies cause a greater contraction than does a
constant Ca21 signal of the same average [Ca21]i (Fig. 8 A).
For the arteriole this was true only for high-frequency oscil-
lations (Fig. 8 B). Although high-frequency oscillations gave
greater contraction, frequencies above 5 spikes/min for the
airway and 0.5 spikes/min for the arteriole cause little addi-
tional contraction. Experimentally, frequencies range from5 to
25 spikes/min for the airway and from 0.5 to 6 spikes/min for
the arteriole (3,4). This means that the Ca21 oscillation fre-
quencies observed in vivo are optimized toward strong con-
traction.
In vivo the average [Ca21]i will also vary with agonist. We
therefore calculated, across a range of values for average
[Ca21]i, the extent of contraction for low-frequency oscilla-
tions and for high-frequency oscillations (Fig. 8, C and D).
We found that, for each average [Ca21]i, high-frequency
oscillations always give greater contraction than do low-
frequency oscillations. In both airway and arteriole, when
[Ca21]i is low, variation in the average [Ca
21]i strongly af-
fects contraction, but at higher values of [Ca21]i, the high-
frequency responses become almost independent of average
[Ca21]i. In contrast the responses to a low-frequency input, or
to a constant input, remain dependent on the average [Ca21]i
even at higher concentrations (Fig. 8, C and D). In airway
SMC, at all average [Ca21]i, both low-frequency and high-
frequency oscillations cause a greater contraction than does a
constant [Ca21]i (Fig. 8 C). However, in arteriole SMC, low-
frequency oscillations always cause a lesser contraction than
does a constant [Ca21]i (Fig. 8 D). Hence, the behavior seen
in Fig. 8, A and B, persists for all values of average [Ca21]i.
Our analysis focused on changes in average [Ca21]i caused
by changes in the spike width at a constant oscillation period.
Similar results are obtained when the spike amplitude is in-
creased (computations not shown).
Calcium oscillations can also be stimulated by KCl, but
these oscillations are qualitatively different from those caused
by agonist, having a much lower frequency of;1 spike/min.
It is observed experimentally that KCl-induced oscillations
cause a smooth contraction of the arteriole but no coordinated
contraction of the airway (3,4).
Our model provides a quantitative explanation of this
observation, as illustrated in Fig. 9. In the model, slow
[Ca21]i oscillations cause strong ﬂuctuations in the airway
SMC length but nearly no ﬂuctuations for arteriole SMCs
(Fig. 9 A). The reason for this is that arteriole SMCs relax
more slowly than airway SMCs (smaller g1, Table 1) and is
thus better able to integrate the slow oscillations. For calcium
oscillations with higher frequencies (.5 spikes/min), the
ﬂuctuations in the SMC length for both airway and arteriole
are almost undetectable. The reason these length ﬂuctuations
remain small at high frequencies is that, according to our
model, the kinetics of cross-bridge formation cannot closely
follow the change in [Ca21]i because the time required for
MLCP activation and cross-bridge attachment/detachment is
much longer than the period of the oscillations.
Because calcium oscillations are not synchronous between
the cells of the airway or arteriole (3,4), the overall contraction
is computed by taking the average over multiple SMCs (six
for the airway, three for the arteriole); the overall changes in
the area are smoother (Fig. 9 B). As expected from the pre-
vious results, the response to a constant [Ca21]i (Fig. 9 B,
dashed line) is always less than the response to the oscillation.
DISCUSSION
Although the basic smooth muscle cross-bridge model based
on actin and myosin interactions was established in 1988, our
FIGURE 8 Frequency response. (A and B) Frequency
dependency of the contractile response of airway and
arteriole, respectively, to calcium oscillations with a con-
stant average [Ca21]i. The steady-state mean relative area
over one period (solid line) varies between two limit cases
for low- and high-frequency oscillations (see Appendix).
High-frequency oscillations give a strong contractile re-
sponse. The mean average calcium is maintained at 0.4 mM
by varying the spike width together with the period so that
their ratio is 0.5 (upper inset). Agonist is kept constant at
a ¼ 1.2. (C and D) Contractile response of airway and
arteriole to calcium oscillations with different average
[Ca21]i. The average [Ca
21]i varies from 0.2 to 0.6 mM
by changing the ratio of spike width to period. For com-
parison the area obtained with a constant signal of equal
average is shown (dashed line). The dot-dashed and dotted
lines give the mean area for the limit cases at low- and
high-frequency oscillations, respectively (see Appendix).
Basal and peak [Ca21]i are 0.2 and 0.6 mM, respectively.
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understanding of enzymes that regulate contraction remains
largely incomplete. In particular, our understanding of
MLCP and its biochemical pathways is rather limited in
comparison to our understanding of MLCK.
Our model suggests that in murine lung slices, both MLCK
andMLCPareupregulated byCa21, but because this activation
occurs on different timescales, airway SMC contraction
adapts tomaintained increases in [Ca21]i, ﬁrst contracting and
then relaxing. Just as importantly, agonists induce contraction
in two ways: ﬁrst, by activating the ‘‘on’’ step (increased
MLCK activity), via an increase in [Ca21]i, and second, by
inactivating the ‘‘off’’ step (decreased MLCP activity). The
implication of these results is that increases in [Ca21]i alone
are less effective in stimulating contraction and that MLCP
must be inactivated by the agonist before signiﬁcant con-
traction can occur (Fig. 3).
The enhancement of Ca21 sensitization by the inhibition of
MLCP by agonist in detergent or toxin-permeabilized SMCs
has been previously reported (14,18–20). MLCP activation
causing relaxation of SMCs has been observed in cells with
elevated cyclic GMP concentration (21–23). However, in
comparison to the responses of lung slices (2,5), the increased
Ca21 sensitivity was limited and activation by Ca21 of
MLCP was not observed. The reasons for the discrepancy
between these results are unclear but may be explained by the
fact that membrane permeabilization changes the integrity of
the SMCs. In the mathematical model we assumed a direct
interaction of Ca21 and MLCP. However, the action of Ca21
is likely to depend on signaling pathways that may have been
disrupted in permeabilized cells. Furthermore, SMCs at dif-
ferent locations of the respiratory tract and from different
animals may not have the same contractile properties.
Although the contractile responses of intrapulmonary ar-
terioles are different from those of airways (4), our model of
SMC contraction can explain the two types of behavior. Our
model predicts that in arteriole SMCs, MLCP activation is
dependent on agonist but not dependent on Ca21 to any
signiﬁcant extent, whereas in airway SMCs, Ca21 activation
of MLCP is the mechanism that leads to adaptation.
The model also predicts that at low agonist concentration,
contraction is mainly controlled by the latch state. Although
application of agonist causes a transient increase in the
number of phosphorylated cross-bridges, most move quickly
to the latch state. At higher agonist concentrations, cross-
bridge phosphorylation makes a greater contribution to
contraction. Removal of agonist or Ca21 quickly causes de-
phosphorylation of myosin. The slower relaxation of arteriole
compared to airway (4,17) is predicted to be due to slower
dissociation of the latch state.
The normal response of airway or arteriole SMCs to ago-
nists consists of Ca21 oscillations (2–5). To address the role
of these signals in modulating airway contraction, we mim-
icked Ca21 oscillations with a periodic step-wise function.
For a given average [Ca21]i, higher oscillation frequency
results in a greater contractile response. Typically, we found
that the contraction obtained with an oscillatory signal was
stronger than the contraction obtained with a constant signal
of equal average [Ca21]i. This may be explained by the
nonlinear dependency of the SMCs’ contractile response on
[Ca21]i (Fig. 9). The peak [Ca
21]i during oscillations is
higher than the [Ca21]i for the constant signal; this causes a
more pronounced rMLC phosphorylation, and so a larger
contractile force. Furthermore, for high-frequency oscilla-
tions, only a small fraction of myosin detaches from actin in
the interspike interval. Our results are in agreement with
previous theoretical and experimental studies that show how
Ca21 oscillations can be the more potent activator for Ca21-
dependent proteins (see, e.g., 24–27).
Arteriole SMCs exhibit their maximal contraction at;0.5
Ca21 spikes/min, whereas airway SMCs do not attain max-
imum contraction until the frequency of the Ca21 spikes
reaches ;5 spikes/min. Because of this difference in the
frequency responses, the low-frequency Ca21 spikes induced
FIGURE 9 Contractile response of airway and arteriole to Ca21 oscilla-
tions. (A) Length changes of an airway (black) and arteriole (gray) SMC to a
step increase in agonist a and frequency at the time points indicated. The
initial Ca21 oscillations (1 spike/min) in the absence of agonist cause strong
variations only in the length of the airway SMC. Ca21 oscillations with
higher frequencies (.5 spike/min) cause continuous contraction in both
airway and arteriole SMC. (B) Relative area changes in response to calcium
oscillations (solid lines) and a constant signal of the same average [Ca21]i
(dashed lines). We assume that six and three SMCs form an airway and
arteriole, respectively. The phase difference in the calcium oscillations
between cells in the airway and arteriole is chosen to be 2p/6 and 2p/3,
respectively. Ca21 oscillations are modeled as a periodic piecewise linear
function. The spike widths are 20, 5, and 2.5 s at a ¼ 0, 0.3, and 1.2,
respectively. The peak [Ca21]i is 1.3 mM at a ¼ 0, and 0.6 mM at a ¼ 0.3
and 1.2. Basal [Ca21]i is 0.2 mM; initial [Ca
21]i is 0.1 mM. The constant
signal [Ca21]i with and without agonist is 0.4 and 0.56 mM, respectively.
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by KCl cause a smooth contraction in arteriole SMC but no
coordinated contraction in airway SMC. It is interesting to
note that, in vivo, calcium oscillations have higher frequen-
cies in airway (5–25 spikes/min) than in arteriole (0.5–6
spikes/min). The model thus predicts that agonist-induced
Ca21 oscillations in both airway and arteriole are optimized
for maximal contraction.
APPENDIX
Parameter estimation
A midpoint implicit upwind method (28) was used to solve the model
equations. We used a time step of Dt ¼ 100 ms and a space discretization of
Dx ¼ 0.05h. A smaller time step or discretization did not improve the
simulations. Parameter values involved in MLCK and MLCP activities and
AM dissociation (Table 1) were determined for the airway by ﬁtting the
model to experimental data from Bai and Sanderson (5) reproduced in Figs.
3, 4, and 6. The experimental data in Figs. 5 and 7 were not used in the ﬁtting
process, although they agree well with the model. For the arteriole model we
used the data from Figs. 6 and 7.
Parameter values involved in the position-dependent attachment and
detachment rates (Table 1) were taken from Mijailovich et al. (8), with the
exception of g1, the dissociation rate constant of the cross-bridges in the latch
state, which was included in the ﬁtting process. With the value given in
Mijailovich et al. (8), the AM cross-bridges would remain immobile in the
latch state and the airway relaxation after agonist removal would be
extremely slow. For b of Eq. 16, we take a value of 2. This allows complete
contraction when all cross-bridges are attached to actin. The average length
of a contractile unit in airway SMCs varies, and a range from 0.7 to 2.2 mm
has been reported (29,30). We take L0/N ¼ 0.7 mm and obtain for the
parameter rescaling the velocity g ¼ L0/(2Nh)b a value of 44.87.
Parameter ﬁtting was done using a Bayesian Markov-Chain Monte Carlo
(MCMC) approach. Brieﬂy, we constructed the posterior distribution of the
parameters p given the data d, Pr(pjd), by using the Bayesian formalism.
Thus
PrðpjdÞ;PrðdjpÞPrðpÞ: (20)
Given a parameter set, we calculate the probability of the data given the
parameters, Pr(djp), by solving the model equations numerically.We assume
that the error at each data point is Gaussian distributed with variance
(0.051)2; this is approximately the variance (5.1%) observed between
different lung slices (5) when the data are plotted as a relative area. We have
logPrðdjpÞ ¼ +
i
ðdi  diÞ2
2ð0:051Þ2; (21)
where di is the computed approximation of the ith data point, di the ith data
point. The prior Pr(p) was chosen uniform for positive parameter values and
0 otherwise. MCMC sampling of the posterior distribution Pr(pjd) was done
using a Metropolis-Hastings algorithm.
FIGURE 10 Representative parameter distributions ob-
tained from MCMC. (A) A typical parameter distribution
with a clear preferred parameter value. (B) A typical
parameter distribution with more than one peak. A mean
and variance is not a useful characterization of this distri-
bution, but the 95% conﬁdence interval still tells us the
most likely range for the parameter. (C) The ratio of
parameters that show correlations has a clear preferred
value.
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The 95% conﬁdence intervals computed from the parameter distributions
are listed in Table 1. Although we cannot determine a speciﬁc value for all of
the parameters, the distributions were all bounded, thus determining the
range in which each parameter is most likely to be found. Fig. 10 shows three
representative traces for the parameter distributions obtained with MCMC.
For the parameters g1, kon1, koff1, and koff2, we found distributions that show a
clearly preferred parameter value (e.g., g1 in Fig. 10 A). Distributions with
more than one peak were observed for the other parameters (e.g., tp in Fig. 10
B). We found that the parameters k1a, k˜2 and k1b, kon2 are correlated and have
a similar multipeaked distribution. However, their ratio is well determined
and gave a distribution with a well-deﬁned peak, as shown in Fig. 10 C for
k1a=k˜2. For the arteriole, we obtained convergence for all parameters (not
shown). The dissociation rate constant of MLCK to Ca21, k1b, has been set to
0.7 mM, the value reported in the literature (31,32). Including this parameter
in the ﬁtting gave a better agreement between model and arteriole data (the
sum of the squared residuals was 2.4 instead of 9.2, F-ratio p , 0.01) but a
nonphysiological low value of 0.27 mM.
To conclude, similar good ﬁts to data were possible with different
combinations of parameters in the range as shown in Table 1. This, however,
does not modify the predictions of the model concerning the role of MLCP
and MLCK regulation, the contribution of the latch state, or the effect of
Ca21 oscillations on the airway and arteriole contractile response. All the
computations done with parameter sets in the given ranges give qualitatively
similar results.
Mean relative airway area
The mean relative area during one oscillation period T, shown in Fig. 8, is
computed from
ÆR:A:æ ¼ 1
T
Z T
0
R:A:ðtÞdt (22)
when the Ca21-driven oscillations of the area have reached a periodic state.
We ﬁrst compute the time average of AM and AMp during one period,
ÆAMæ and ÆAMpæ respectively and then calculate the force fromRN
N xðÆAMæ1ÆAMæpÞdx. For low- and high-frequency Ca21 oscillations,
we derived analytical expressions for ÆAMæ and ÆAMæp, which have been used
to compute the mean area for these two limiting cases (Fig. 8, C and D).
For low-frequency oscillations the period T and spike width d are much
larger than the characteristic time of the system. This means that when the
calcium concentration changes, the airway and MLCP have enough time to
reach a new steady state. Neglecting the transient from one steady state to
another we obtain
ÆAMpæ ¼ 1
T
Z T
0
AMpdt ¼ AMpðc1ÞD1AMpðc0Þð1 DÞ;
(23)
where D ¼ d/T, c0 and c1 are the basal and peak [Ca21]i during oscillations.
The steady state AMpðcÞ attained at a [Ca21]i of c is calculated by solving
Eqs. 5–7
AMpðcÞ ¼ fpðxÞk1ðgðxÞ1 k1Þ
B
(24)
with
B ¼ ½k11 k˜2PðcÞ2½ðfpðxÞ1 gpðxÞÞðgðxÞ1 k1Þ1 gðxÞk˜2PðcÞ2
(25)
and PðcÞ ¼ konðcÞ=ðkonðcÞ1koffÞ. Similar expressions are derived for ÆAMæ
with
AMðcÞ ¼ fpðxÞk1k˜2PðcÞ
2
B
: (26)
For high-frequency oscillations, the amplitude of the cross-bridges and
MLCP oscillations is small compared to their mean and the system integrates
over the calcium signal. For instance, the fraction of active MLCP can be
written as P¼ ÆPæ1 dP, with average ÆPæ and amplitude dP. Integrating Eq.
1 gives
tp
T
Z T
0
dP
dt
¼ Æk1æ ÆPæÆkonæ koffÆPæ 1
T
Z T
0
kon; dPdt ¼ 0
(27)
with an average activation rate Ækonæ ¼ kon(c1)D 1 kon(c0)(1  D). Because
dP  1 the last term in the previous equation can be neglected so that
ÆPæ ¼ Ækonæ
Ækonæ1 koff
: (28)
Similar reasoning can be used to obtain the average attached cross-bridges.
ÆAMæp and ÆAMæ are given, respectively, by Eqs. 24 and 26 where k1 and P
have been replaced with their mean Æk1æ ¼ k1(c1)D1 k1(c0)(1  D) and ÆPæ.
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